CALR and neoplasm: To assess if integrin modulation of tumor cells functionally modulates their ability to be phagocytosed by macrophages, we first confirmed that oxaliplatin-treated β1−/− cells exhibit higher surface CRT when compared to WT cells (Figure 6E).